FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2885710033> ?p ?o ?g. }

• W2885710033 endingPage "20" @default.
• W2885710033 startingPage "12" @default.
• W2885710033 abstract "In the pig-to-baboon artery patch model with no immunosuppressive therapy, a graft from an α1,3-galactosyltransferase gene-knockout (GTKO) pig elicits a significant anti-nonGal IgG response, indicating sensitization to the graft. A costimulation blockade-based regimen, e.g., anti-CD154mAb or anti-CD40mAb, prevents sensitization. However, neither of these agents is currently FDA-approved. The aim of the present study was to determine the efficacy of FDA-approved agents on the T and B cell responses.Artery patch xenotransplantation in baboons was carried out using GTKO/CD46 pigs with (n = 2) or without (n = 1) the mutant transgene for CIITA-knockdown. Immunosuppressive therapy consisted of induction with ATG and anti-CD20mAb, and maintenance with different combinations of CTLA4-Ig, tacrolimus, and rapamycin. In addition, all 3 baboons received daily corticosteroids, the IL-6R blocker, tocilizumab, at regular intervals, and the TNF-α blocker, etanercept, for the first 2 weeks. Recipient blood was monitored for anti-nonGal antibody levels by flow cytometry (using GTKO/CD46 pig aortic endothelial cells), and mixed lymphocyte reaction (MLR). CD22+B cell profiles (naïve [IgD+/CD27-], non-switched memory [IgD+/CD27+], and switched memory [IgD-/CD27+] B cell subsets) were measured by flow cytometry. At 6 months, the baboons were euthanized and the grafts were examined histologically.No elicited anti-pig antibodies developed in any baboon. The frequency of naïve memory B cells increased significantly (from 34% to 90%, p = 0.0015), but there was a significant decrease in switched memory B cells (from 17% to 0.5%, p = 0.015). MLR showed no increase in the proliferative T cell response in those baboons that had received CTLA4-Ig (n = 2). Histological examination showed few or no features of rejection in any graft.The data suggest that immunosuppressive therapy with only FDA-approved agents may be adequate to prevent an adaptive immune response to a genetically-engineered pig graft, particularly if CTLA4-Ig is included in the regimen, in part because the development of donor-specific memory B cells is inhibited." @default.
• W2885710033 created "2018-08-22" @default.
• W2885710033 creator A5004818290 @default.
• W2885710033 creator A5015609650 @default.
• W2885710033 creator A5021163102 @default.
• W2885710033 creator A5027326762 @default.
• W2885710033 creator A5038934486 @default.
• W2885710033 creator A5047542433 @default.
• W2885710033 creator A5050364060 @default.
• W2885710033 creator A5052576326 @default.
• W2885710033 creator A5064711465 @default.
• W2885710033 creator A5066983840 @default.
• W2885710033 creator A5075124399 @default.
• W2885710033 creator A5082539982 @default.
• W2885710033 creator A5085492854 @default.
• W2885710033 creator A5087164059 @default.
• W2885710033 creator A5091887863 @default.
• W2885710033 date "2018-12-01" @default.
• W2885710033 modified "2023-10-17" @default.
• W2885710033 title "B cell phenotypes in baboons with pig artery patch grafts receiving conventional immunosuppressive therapy" @default.
• W2885710033 cites W1033082685 @default.
• W2885710033 cites W1485526722 @default.
• W2885710033 cites W1536156589 @default.
• W2885710033 cites W1908439678 @default.
• W2885710033 cites W1925780210 @default.
• W2885710033 cites W1928404074 @default.
• W2885710033 cites W1939671844 @default.
• W2885710033 cites W1946392463 @default.
• W2885710033 cites W1954897628 @default.
• W2885710033 cites W1958424241 @default.
• W2885710033 cites W1964509867 @default.
• W2885710033 cites W1965348160 @default.
• W2885710033 cites W1973388628 @default.
• W2885710033 cites W1981486037 @default.
• W2885710033 cites W1982836586 @default.
• W2885710033 cites W1989206225 @default.
• W2885710033 cites W1999227650 @default.
• W2885710033 cites W2002448034 @default.
• W2885710033 cites W2020151483 @default.
• W2885710033 cites W2025571326 @default.
• W2885710033 cites W2025943017 @default.
• W2885710033 cites W2027284410 @default.
• W2885710033 cites W2029174718 @default.
• W2885710033 cites W2056353073 @default.
• W2885710033 cites W2057607651 @default.
• W2885710033 cites W2059443179 @default.
• W2885710033 cites W2059791530 @default.
• W2885710033 cites W2065544328 @default.
• W2885710033 cites W2068128688 @default.
• W2885710033 cites W2070857566 @default.
• W2885710033 cites W2073119029 @default.
• W2885710033 cites W2073734090 @default.
• W2885710033 cites W2077286174 @default.
• W2885710033 cites W2078869001 @default.
• W2885710033 cites W2085486530 @default.
• W2885710033 cites W2086080135 @default.
• W2885710033 cites W2097147259 @default.
• W2885710033 cites W2111185199 @default.
• W2885710033 cites W2120569077 @default.
• W2885710033 cites W2143196300 @default.
• W2885710033 cites W2143204362 @default.
• W2885710033 cites W2149055995 @default.
• W2885710033 cites W2151705643 @default.
• W2885710033 cites W2156097869 @default.
• W2885710033 cites W2170780801 @default.
• W2885710033 cites W2291500522 @default.
• W2885710033 cites W2304823366 @default.
• W2885710033 cites W2315479515 @default.
• W2885710033 cites W2512510124 @default.
• W2885710033 cites W2557775641 @default.
• W2885710033 cites W2588200867 @default.
• W2885710033 cites W2595269307 @default.
• W2885710033 cites W2595642260 @default.
• W2885710033 cites W2617078979 @default.
• W2885710033 cites W2619072237 @default.
• W2885710033 cites W2735827335 @default.
• W2885710033 cites W2892202394 @default.
• W2885710033 doi "https://doi.org/10.1016/j.trim.2018.08.005" @default.
• W2885710033 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6249078" @default.
• W2885710033 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30092338" @default.
• W2885710033 hasPublicationYear "2018" @default.
• W2885710033 type Work @default.
• W2885710033 sameAs 2885710033 @default.
• W2885710033 citedByCount "9" @default.
• W2885710033 countsByYear W28857100332018 @default.
• W2885710033 countsByYear W28857100332019 @default.
• W2885710033 countsByYear W28857100332020 @default.
• W2885710033 countsByYear W28857100332021 @default.
• W2885710033 countsByYear W28857100332022 @default.
• W2885710033 crossrefType "journal-article" @default.
• W2885710033 hasAuthorship W2885710033A5004818290 @default.
• W2885710033 hasAuthorship W2885710033A5015609650 @default.
• W2885710033 hasAuthorship W2885710033A5021163102 @default.
• W2885710033 hasAuthorship W2885710033A5027326762 @default.
• W2885710033 hasAuthorship W2885710033A5038934486 @default.
• W2885710033 hasAuthorship W2885710033A5047542433 @default.
• W2885710033 hasAuthorship W2885710033A5050364060 @default.
• W2885710033 hasAuthorship W2885710033A5052576326 @default.

• next